Prevention of ischemia-reperfusion injury in cardiac surgery: Therapeutic strategies targeting signaling pathways
Authors:
- 1 March 2015
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 149 (3) , 910-911
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Single-dose rosuvastatin ameliorates lung ischemia–reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertensionThe Journal of Thoracic and Cardiovascular Surgery, 2015
- Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROSNature, 2014
- Statins Exert the Pleiotropic Effects Through Small GTP-Binding Protein Dissociation Stimulator Upregulation With a Resultant Rac1 DegradationArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Atorvastatin in Pulmonary Arterial Hypertension (APATH) studyEuropean Respiratory Journal, 2012
- Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial HypertensionCirculation, 2011
- Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressionsBrain Research, 2010
- Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase proteinWorld Journal of Gastroenterology, 2006
- Statin Protects Endothelial Nitric Oxide Synthase Activity in Hypoxia-Induced Pulmonary HypertensionArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia–reperfusion injury in rat heartsCardiovascular Research, 2005